Requirement for protein kinase R in interleukin-1α-stimulated effects in cartilage

Biochemical Pharmacology

Volumn 74, Issue 11, 2007, Pages 1636-1641

  Tam, Christine L ^a   Hofbauer, Maria ^a   Towle, Christine A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cartilage; Cyclooxygenase 2; Degradation; Eukaryotic initiation factor 2; Interleukin 1; Protein kinase R

Indexed keywords

CYCLOOXYGENASE 2; ENZYME INHIBITOR; GLYCOSAMINOGLYCAN POLYSULFATE; INITIATION FACTOR 2; INTERLEUKIN 1ALPHA; PROSTAGLANDIN E2; PROTEIN KINASE R; PROTEOGLYCAN;

ANIMAL CELL; ARTICLE; CARTILAGE; CONTROLLED STUDY; ENZYME ACTIVITY; EXPLANT; IC 50; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARPAL JOINTS; CARTILAGE; CATTLE; CHONDROCYTES; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 2; DITHIOTHREITOL; DOSE-RESPONSE RELATIONSHIP, DRUG; EIF-2 KINASE; EUKARYOTIC INITIATION FACTOR-2; GLYCOSAMINOGLYCANS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1ALPHA; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEOGLYCANS; SULFATES; TIME FACTORS;

EID: 35348945870     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.08.002     Document Type: Article

References (36)

1. Buckwalter J.A., Martin J., and Mankin H.J. Synovial joint degeneration and the syndrome of osteoarthritis. Instr Course Lect 49 (2000) 481-489
2. Chevalier X., Giraudeau B., Conrozier T., Marliere J., Kiefer P., and Goupille P. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study. J Rheumatol 32 (2005) 1317-1323
3. Dayer J.M. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology (Oxford) 42 Suppl. 2 (2003) ii3-ii10
4. Hwang S.G., Yu S.S., and Poo H. Chun JS c-Jun/activator protein-1 mediates interleukin-1beta-induced dedifferentiation but not cyclooxygenase-2 expression in articular chondrocytes. J Biol Chem 280 (2005) 29780-29787
5. Liacini A., Sylvester J., Li W.Q., and Zafarullah M. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 21 (2002) 251-262
6. Williams B.R. PKR; a sentinel kinase for cellular stress. Oncogene 18 (1999) 6112-6120
7. Garcia M.A., Gil J., Ventoso I., Guerra S., Domingo E., Rivas C., et al. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70 (2006) 1032-1060
8. Donze O., Deng J., Curran J., Sladek R., Picard D., and Sonenberg N. The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J 23 (2004) 564-571
9. Patel R.C., and Sen G.C. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J 17 (1998) 4379-4390
10. Ladiges W., Morton J., Blakely C., and Gale M. Tissue specific expression of PKR protein kinase in aging B6D2F1 mice. Mech Ageing Dev 114 (2000) 123-132
11. Gilbert S.J., Duance V.C., and Mason D.J. Identification of changes in chondrocyte gene expression in an in vivo animal model of osteoarthritis. Osteoarthritis Cartilage 8 (2000) S33
12. Gilbert S.J., Duance V.C., and Mason D.J. Tumour necrosis factor alpha up-regulates protein kinase R (PKR)-activating protein (PACT) and increases phosphorylation of PKR and eukaryotic initiation factor 2-alpha in articular chondrocytes. Biochem Soc Trans 30 (2002) 886-889
13. Oliver B.L., Cronin C.G., Zhang-Benoit Y., Goldring M.B., and Tanzer M.L. Divergent stress responses to IL-1beta, nitric oxide, and tunicamycin by chondrocytes. J Cell Physiol 204 (2005) 45-50
14. Gilbert S.J., Duance V.C., and Mason D.J. Does protein kinase R mediate TNF-alpha- and ceramide-induced increases in expression and activation of matrix metalloproteinases in articular cartilage by a novel mechanism?. Arthritis Res Ther 6 (2004) R46-R55
15. Hosoi T., Matsunami N., Nagahama T., Okuma Y., Ozawa K., Takizawa T., et al. 2-Aminopurine inhibits leptin receptor signal transduction. Eur J Pharmacol 553 (2006) 61-66
16. Posti K., Leinonen S., Tetri S., Kottari S., Viitala P., Pelkonen O., et al. Modulation of murine phenobarbital-inducible CYP2A5, CYP2B10 and CYP1A enzymes by inhibitors of protein kinases and phosphatases. Eur J Biochem 264 (1999) 19-26
17. Farndale R.W., Buttle D.J., and Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883 (1986) 173-177
18. Le D., Hofbauer M.A., and Towle C.A. Differential effects of hyperosmotic challenge on interleukin-1-activated pathways in bovine articular cartilage. Arch Biochem Biophys 445 (2006) 1-8
19. Bertolotti A., Zhang Y., Hendershot L.M., Harding H.P., and Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2 (2000) 326-332
20. Patel C.V., Handy I., Goldsmith T., and Patel R.C. PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J Biol Chem 275 (2000) 37993-37998
21. Towle C.A., Mankin H.J., Avruch J., and Treadwell B.V. Insulin promoted decrease in the phosphorylation of protein synthesis initiation factor eIF-2. Biochem Biophys Res Commun 121 (1984) 134-140
22. Jammi N.V., Whitby L.R., and Beal P.A. Small molecule inhibitors of the RNA-dependent protein kinase. Biochem Biophys Res Commun 308 (2003) 50-57
23. Page G., Rioux Bilan A., Ingrand S., Lafay-Chebassier C., Pain S., Perault Pochat M.C., et al. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience 139 (2006) 1343-1354
24. Shimazawa M., and Hara H. Inhibitor of double stranded RNA-dependent protein kinase protects against cell damage induced by ER stress. Neurosci Lett 409 (2006) 192-195
25. Edwards M.R., Hewson C.A., Laza-Stanca V., Lau H.T., Mukaida N., Hershenson M.B., et al. Protein kinase R, IkappaB kinase-beta and NF-kappaB are required for human rhinovirus induced pro-inflammatory cytokine production in bronchial epithelial cells. Mol Immunol 44 (2007) 1587-1597
26. Kornman K.S. Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am J Clin Nutr 83 (2006) S475-S483
27. Apte R.N., Krelin Y., Song X., Dotan S., Recih E., Elkabets M., et al. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. Eur J Cancer 42 (2006) 751-759
28. Apte R.N., Dotan S., Elkabets M., White M.R., Reich E., Carmi Y., et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 25 (2006) 387-408
29. Merhi-Soussi F., Kwak B.R., Magne D., Chadjichristos C., Berti M., Pelli G., et al. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res 66 (2005) 583-593
30. Gosselin D., and Rivest S. Role of IL-1 and TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system. Brain Behav Immun 21 (2007) 281-289
31. Mathy-Hartert M., Deby-Dupont G.P., Reginster J.Y., Ayache N., Pujol J.P., and Henrotin Y.E. Regulation by reactive oxygen species of interleukin-1beta, nitric oxide and prostaglandin E(2) production by human chondrocytes. Osteoarthritis Cartilage 10 (2002) 547-555
32. Cuzzocrea S., and Salvemini D. Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes. Kidney Int 71 (2007) 290-297
33. Clancy R., Varenika B., Huang W., Ballou L., Attur M., Amin A.R., et al. Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol 165 (2000) 1582-1587
34. Mollace V., Muscoli C., Masini E., Cuzzocrea S., and Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57 (2005) 217-252
35. Simmons D.L., Botting R.M., and Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56 (2004) 387-437
36. Trostchansky A., O'Donnell V.B., Goodwin D.C., Landino L.M., Marnett L.J., Radi R., et al. Interactions between nitric oxide and peroxynitrite during prostaglandin endoperoxide H synthase-1 catalysis: a free radical mechanism of inactivation. Free Radic Biol Med 42 (2007) 1029-1038